The six early Stage Researchers (ESRs) are being trained in advanced glycomics technologies arising from the EU-FP7 HighGlycan programme, as well as other orthogonal glycoanalytical methods developed by consortium members. Each ESR is employed by one of the three beneficiaries, based in the Netherlands, in Croatia and in England, respectively. The candidates are supported by H2020-MSCA-ITN funding for a maximum of 36 months. Salary includes a living allowance, adjusted for location, and a mobility allowance. An additional family allowance may apply depending on circumstances.
GlySign welcomed applications from all suitably qualified candidates, irrespective of gender, disability, marital or parental status, racial, ethnic or social origin, colour, religion, belief or sexual orientation. Besides holding a Master’s degree in life sciences or a related field / degree, a good level of English (spoken and written) was one of the main criteria for selection. The candidates should be good communicators with the ability to develop work relationships and have strong analytical skills particularly with an attention to detail. They should be an independent thinker with a proven ability to project manage their work and meet deadlines. They should be able to work efficiently as part of a team and to build upon our collaborations. For specific requirements, please refer to the individual job descriptions.
The selection for each post included:
► pre-selection (based on CV and motivation letter) by our international selection committee (composed of experts from different fields and from both private and public sector)
► web-based video interview
► In loco interview
Given that the positions are funded by the European Commission on a H2020-MSCA-ITN, eligibility restrictions apply: